Close Menu
May 02, 2019
Sponsored by
SeraCare

Multi-Center Evaluation of Circulating Tumor DNA Assays

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Measurements of circulating tumor DNA (ctDNA) hold great potential to detect residual disease and monitor therapeutic response and tumor evolution.

Download this poster and watch the video to learn more about this trial which covers the entire workflow from sample preparation through variant reporting.

Sponsored by